First Time Loading...
B

Biolight Life Sciences Ltd
TASE:BOLT

Watchlist Manager
Biolight Life Sciences Ltd
TASE:BOLT
Watchlist
Price: 427.2 ILS 5.22% Market Closed
Updated: May 21, 2024
Section:
 

Wall Street
Price Targets

BOLT Price Targets Summary
Biolight Life Sciences Ltd

There are no price targets for BOLT.
BOLT Lowest Forecast
Wall Street Target
Not Available
BOLT Average Forecast
Wall Street Target
Not Available
BOLT Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Biolight Life Sciences Ltd Competitors:
Price Targets
W
2268
WuXi XDC Cayman Inc
98% Upside
QGEN
Qiagen NV
13% Upside
WST
West Pharmaceutical Services Inc
22% Upside
DXRX
Diaceutics PLC
43% Upside
W
2268
WuXi XDC Cayman Inc
98% Upside
QGEN
Qiagen NV
13% Upside
WST
West Pharmaceutical Services Inc
22% Upside
DXRX
Diaceutics PLC
43% Upside
CTKB
Cytek Biosciences Inc
71% Upside
IQV
IQVIA Holdings Inc
21% Upside
QTRX
Quanterix Corp
70% Upside
R
301333
R&G PharmaStudies Co Ltd
44% Upside

Revenue
Forecast

Revenue Estimate
Biolight Life Sciences Ltd

For the last 8 years the compound annual growth rate for Biolight Life Sciences Ltd's revenue is -27%. The projected CAGR for the next 6 years is 63%.

-27%
Past Growth
63%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Biolight Life Sciences Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Biolight Life Sciences Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
BOLT intrinsic value, competitors valuation, and company profile.
DCF Valuation
BOLT stock valuation using Discount Cash Flow valuation method.
Relative Valuation
BOLT stock valuation using valuation multiples.
Wall Street Estimates
BOLT price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
BOLT stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BOLT's stock price target?
Not Available

BOLT doesn't have any price targets made by Wall Street professionals.

What is Biolight Life Sciences Ltd's Revenue forecast?
Projected CAGR
63%

For the last 8 years the compound annual growth rate for Biolight Life Sciences Ltd's revenue is -27%. The projected CAGR for the next 6 years is 63%.

ALPHA SPREAD
Join more than 139,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.